Hindsight is the proverbial you know what....but hey i guess you're perfect and have never experienced that feeling before.
Biotech is hard, i mean really hard. I know as I work in this industry. Things take time, exorbitant amounts of money but more importantly ridiculous amounts of patience. Ethics approvals especially for multicentre projects can be complex and requires finesse as each hospital/clinical site has different levels of governance. There is also the time taken to develop collaborations and relationships with the clinical team to do the trial at a new centre.
Its a good step forward that a second site has come on board. Lets hope more will come online as the australia P3 trial is commenced.
Ann: Phase 2 Synovial Fluid Biomarker Study Update, page-21
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.010(4.35%) |
Mkt cap ! $83.95M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 25.0¢ | 23.0¢ | $145.7K | 618.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 7782 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 15715 | 4 |
View Market Depth
| Last trade - 14.55pm 06/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |